Mettler-Toledo International, Inc. $MTD Holdings Decreased by Bank of New York Mellon Corp

Bank of New York Mellon Corp reduced its position in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 9.0% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 822,567 shares of the medical instruments supplier’s stock after selling 81,697 shares during the quarter. Bank of New York Mellon Corp’s holdings in Mettler-Toledo International were worth $1,009,791,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently added to or reduced their stakes in the company. Corient Private Wealth LLC grew its holdings in shares of Mettler-Toledo International by 91.8% during the second quarter. Corient Private Wealth LLC now owns 140,267 shares of the medical instruments supplier’s stock valued at $164,775,000 after purchasing an additional 67,149 shares during the last quarter. Stance Capital LLC bought a new position in Mettler-Toledo International during the 2nd quarter worth $2,012,000. Sound Income Strategies LLC increased its position in Mettler-Toledo International by 477.8% in the second quarter. Sound Income Strategies LLC now owns 52 shares of the medical instruments supplier’s stock worth $61,000 after buying an additional 43 shares during the period. Claret Asset Management Corp bought a new stake in Mettler-Toledo International in the second quarter valued at $235,000. Finally, Acadian Asset Management LLC boosted its holdings in shares of Mettler-Toledo International by 12.3% during the second quarter. Acadian Asset Management LLC now owns 2,823 shares of the medical instruments supplier’s stock valued at $3,312,000 after acquiring an additional 310 shares during the period. 95.07% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of analysts recently weighed in on the stock. Barclays dropped their price objective on shares of Mettler-Toledo International from $1,600.00 to $1,550.00 and set an “overweight” rating on the stock in a report on Monday, December 15th. Bank of America raised Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,600.00 price target on the stock in a report on Monday, December 15th. Evercore ISI increased their price objective on Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the stock an “outperform” rating in a report on Tuesday, October 7th. Stifel Nicolaus lifted their target price on Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the company a “buy” rating in a research note on Monday, November 10th. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Mettler-Toledo International in a research note on Monday, December 29th. Six research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat.com, Mettler-Toledo International presently has a consensus rating of “Hold” and a consensus target price of $1,441.67.

Mettler-Toledo International Price Performance

MTD opened at $1,424.09 on Wednesday. The business has a 50 day moving average price of $1,434.18 and a two-hundred day moving average price of $1,350.02. The company has a market capitalization of $29.09 billion, a price-to-earnings ratio of 35.51, a price-to-earnings-growth ratio of 4.24 and a beta of 1.41. Mettler-Toledo International, Inc. has a 1-year low of $946.69 and a 1-year high of $1,525.17.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $10.62 by $0.53. Mettler-Toledo International had a negative return on equity of 426.96% and a net margin of 21.20%.The company had revenue of $1.03 billion for the quarter, compared to analysts’ expectations of $997.36 million. During the same period last year, the firm earned $10.21 EPS. The firm’s revenue for the quarter was up 7.9% on a year-over-year basis. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS and its FY 2025 guidance at 42.050-42.250 EPS. Equities analysts expect that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.

Insider Transactions at Mettler-Toledo International

In other Mettler-Toledo International news, CEO Patrick Kaltenbach sold 2,000 shares of the company’s stock in a transaction dated Wednesday, November 12th. The shares were sold at an average price of $1,462.50, for a total value of $2,925,000.00. Following the completion of the sale, the chief executive officer directly owned 3,670 shares of the company’s stock, valued at approximately $5,367,375. This represents a 35.27% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider La Guerroniere Marc De sold 6,055 shares of the firm’s stock in a transaction dated Tuesday, November 25th. The shares were sold at an average price of $1,488.18, for a total transaction of $9,010,929.90. Following the transaction, the insider owned 187 shares of the company’s stock, valued at approximately $278,289.66. This trade represents a 97.00% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 19,565 shares of company stock valued at $28,683,737 in the last quarter. 0.77% of the stock is owned by company insiders.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.